Communities
  Subjects
  All Items
globalchange

Usage Statistics

 Help
Stats Condition
Stats Scope: Item【Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP)】
Detail Stats:
Robots Visit: Include  Exclude  Only Robots
Inner Visit: Include  Exclude  Only Inners 

Statistics
Total Visits:35  Total Downloads:0  
Export To Excel
Stats By Year
Year Visits Downloads
2021 2 0
2022 10 0
2023 11 0
2024 10 0
2025 2 0
page 1 of 1  Jump to Page [First Page]  [Previous Page]  [Next Page]  [Last Page]